ABG Analytics logo
Get updates

Celgene Corp (NASDAQ: CELG)

DRUGS - Biotechnology
Stock price data as of 01/18/2019
Closing price: 86.27
Support price level: $75.18
Resistance price level: N/A
Relative strength index (14-day RSI) 90.0
Beta 1.58
  • CELG is one of this month's top performers with a return of 31.5 percent, beating 90 percent of stocks in the S&P-100.

  • The price of this high-beta stock is expected to increase by 1.58% for every 1% increase in the S&P-500.

  • CELG is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 49.0%.

  • Volatility is forecast to fall over the next month.

  • CELG is above its 200-day moving average, providing a measure of support for long positions.

  • With RSI > 70, CELG is overbought. Odds slightly favor a short-term price reversal.

  • Price broke above prior resistance level - a short-term bullish signal.

Low High Price as % of Range
$59.21 $105.17 65.5%
200 day 50 day 20 day 10 day
$81.86 $72.96 $77.04 $87.24
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
31.8% 34.9% 49.0% 39.2%
There is an estimated 5% probability that the stock price of Celgene Corp will fall by more than:
  • 13.3% in the next week.

  • 22.2% in the next month.

  • 67.0% in the next year.